Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

ProShares Ultra Nasdaq Biotechnology

+ Add to Watchlist

BIB:US

87.1600 USD 1.2900 1.46%

As of 10:20:31 ET on 06/02/2015.

Snapshot for ProShares Ultra Nasdaq Biotechnology (BIB)

Open: 87.3800 High - Low: 88.0100 - 86.2600 Primary Exchange: NASDAQ GM
Volume: 210,045 52-Week Range: 39.2550 - 94.8700 Beta vs NBI: 1.6880

ETF Chart for BIB

No chart data available.
  • BIB:US 87.0100
  • 1D
  • 1M
  • 1Y
88.4500
Interactive BIB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BIB

ProShares Ultra Nasdaq Biotechnology is an an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to twice (200%) the return of the Nasdaq Biotechnology Index.

Inception Date: 2010-04-08 Telephone: 1-240-497-6400
Managers: HOWARD S RUBIN / TODD BRUCE JOHNSON
Web Site: www.proshares.com

Fundamentals for BIB

NAV (on 2015-06-01) 88.5100
Assets (M) (on 2015-06-01) 978.0510
Shares out (M) 11.05
Market Cap (M) 977.37
% Premium -0.07
Average 52-Week % Premium 0.0146
Fund Leveraged Y
Fund Leverage Percent 200.0000 %

Dividends for BIB

Dividend Type Income
Dividend Frequency Irreg
Last Dividend Net (on 2010-09-21) 0.0110
Dividend Yield (ttm) -%

Performance for BIB

1-Month +12.29% 1-Year +119.02%
3-Month +15.07% 3-Year +99.36%
Year To Date +40.96% 5-Year +73.88%
Expense Ratio 0.95

Top Fund Holdings for BIB

Filing Date: 03/31/2015
Name Position Value % of Total
Biogen Inc 108,551 45,834,574 5.671%
Amgen Inc 281,899 45,061,555 5.575%
Celgene Corp 365,847 42,174,842 5.218%
Gilead Sciences Inc 429,454 42,142,321 5.214%
Regeneron Pharmaceuticals Inc 81,846 36,951,832 4.572%
Vertex Pharmaceuticals Inc 186,138 21,958,700 2.717%
Alexion Pharmaceuticals Inc 123,250 21,359,225 2.643%
Illumina Inc 113,733 21,113,394 2.612%
Mylan NV 315,581 18,729,732 2.317%
BioMarin Pharmaceutical Inc 133,795 16,673,533 2.063%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil